Oxycodone Terminated Phase 3 Trials for Osteoarthritis (OA) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00985621Tanezumab In Osteoarthritis Of The Hip Or Knee
NCT00312221Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Osteoarthritis Pain